Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors

NCT03915678 is registered in ClinicalTrials.gov with Institut Bergonié as lead sponsor.

NCT NCT03915678
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03915678 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Atezolizumab Combined With BDB001 AnD Immunogenic Radiotherapy in Patients With Advanced Solid Tumors
Lead sponsor
Institut Bergonié
Phase
Phase 2
Overall status
Active, not recruiting
Start date
March 31, 2021
Completion date
December 31, 2027
Enrollment
247 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

bladder cancer, melanoma, non small cell lung cancer, pancreatic cancer, solid tumor, adult, triple negative breast cancer, virus-associated tumors